Shiri Zayit-Soudry1, Nicolas Sippl-Swezey2, Travis C Porco3, Stephanie K Lynch1, Reema Syed1, Kavitha Ratnam1, Moreno Menghini1, Austin J Roorda4, Jacque L Duncan1. 1. Department of Ophthalmology University of California, San Francisco, California, United States. 2. Department of Ophthalmology University of California, San Francisco, California, United States 2Francis I. Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California, United States. 3. Francis I. Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California, United States. 4. School of Optometry and Vision Science Graduate Group, University of California, Berkeley, California, United States.
Abstract
PURPOSE: To determine short-term variability of adaptive optics scanning laser ophthalmoscopy (AOSLO)-derived cone spacing measures in eyes with inherited retinal degenerations (IRD) and in normal eyes. METHODS: Twenty IRD patients and 10 visually normal subjects underwent AOSLO imaging at two visits separated by no more than 1 month (NCT00254605). Cone spacing was measured in multiple macular regions in each image by three independent graders. Variability of cone spacing measures between visits, between graders, and between eyes was determined and correlated with standard clinical measures. RESULTS: Cone spacing was measured in 2905 regions. Interobserver agreement was high both in normal eyes and eyes with IRD (mean intraclass correlation coefficient [ICC] = 0.838 for normal and 0.892 for eyes with IRD). Cone spacing measures were closely correlated between visits (ICC > 0.869 for both study groups). Mean relative intervisit spacing difference (absolute difference in measures divided by the mean at each region) was 4.0% for normal eyes and 4.9% for eyes with IRD. Cone spacing measures from fellow eyes of the same subject showed strong agreement for all subjects (ICC > 0.85 for both study groups). CONCLUSIONS: Adaptive optics scanning laser ophthalmoscopy-derived macular cone spacing measures were correlated between observers, visits, and fellow eyes of the same subject in normal eyes and in eyes with IRD. This information may help establish the role of cone spacing measures derived from images of the cone mosaic obtained with AOSLO as a sensitive biomarker for longitudinal tracking of photoreceptor loss during disease progression and in response to treatment. (ClinicalTrials.gov number, NCT00254605.).
PURPOSE: To determine short-term variability of adaptive optics scanning laser ophthalmoscopy (AOSLO)-derived cone spacing measures in eyes with inherited retinal degenerations (IRD) and in normal eyes. METHODS: Twenty IRD patients and 10 visually normal subjects underwent AOSLO imaging at two visits separated by no more than 1 month (NCT00254605). Cone spacing was measured in multiple macular regions in each image by three independent graders. Variability of cone spacing measures between visits, between graders, and between eyes was determined and correlated with standard clinical measures. RESULTS: Cone spacing was measured in 2905 regions. Interobserver agreement was high both in normal eyes and eyes with IRD (mean intraclass correlation coefficient [ICC] = 0.838 for normal and 0.892 for eyes with IRD). Cone spacing measures were closely correlated between visits (ICC > 0.869 for both study groups). Mean relative intervisit spacing difference (absolute difference in measures divided by the mean at each region) was 4.0% for normal eyes and 4.9% for eyes with IRD. Cone spacing measures from fellow eyes of the same subject showed strong agreement for all subjects (ICC > 0.85 for both study groups). CONCLUSIONS: Adaptive optics scanning laser ophthalmoscopy-derived macular cone spacing measures were correlated between observers, visits, and fellow eyes of the same subject in normal eyes and in eyes with IRD. This information may help establish the role of cone spacing measures derived from images of the cone mosaic obtained with AOSLO as a sensitive biomarker for longitudinal tracking of photoreceptor loss during disease progression and in response to treatment. (ClinicalTrials.gov number, NCT00254605.).
Authors: Jia Qin; Nicholas Rinella; Qinqin Zhang; Hao Zhou; Jessica Wong; Michael Deiner; Austin Roorda; Travis C Porco; Ruikang K Wang; Daniel M Schwartz; Jacque L Duncan Journal: Invest Ophthalmol Vis Sci Date: 2018-12-03 Impact factor: 4.799
Authors: Niamh Wynne; Jenna A Cava; Mina Gaffney; Heather Heitkotter; Abigail Scheidt; Jenny L Reiniger; Jenna Grieshop; Kai Yang; Wolf M Harmening; Robert F Cooper; Joseph Carroll Journal: Biomed Opt Express Date: 2022-08-01 Impact factor: 3.562
Authors: Young Ju Lew; Nicholas Rinella; Jia Qin; Joanna Chiang; Anthony T Moore; Travis C Porco; Austin Roorda; Jacque L Duncan Journal: Am J Ophthalmol Date: 2017-11-16 Impact factor: 5.258
Authors: Lynn W Sun; Ryan D Johnson; Christopher S Langlo; Robert F Cooper; Moataz M Razeen; Madia C Russillo; Alfredo Dubra; Thomas B Connor; Dennis P Han; Mark E Pennesi; Christine N Kay; David V Weinberg; Kimberly E Stepien; Joseph Carroll Journal: Invest Ophthalmol Vis Sci Date: 2016-05-01 Impact factor: 4.799